How Do Wegovy and Mounjaro Side Effects Compare?
Understanding Side Effects of Wegovy vs Mounjaro Mechanisms
The side effects of Wegovy differ from Mounjaro primarily due to their distinct mechanisms of action. Wegovy contains semaglutide, which targets GLP-1 receptors specifically, whilst Mounjaro's tirzepatide acts on both GIP and GLP-1 receptors simultaneously. This dual-receptor approach in Mounjaro may result in different gastrointestinal side effect patterns compared to Wegovy's single-receptor targeting. Both medications slow gastric emptying, which explains why nausea, vomiting, and diarrhoea are common initial side effects for both treatments.
When examining side effects of Wegovy specifically, the most frequently reported include nausea (affecting up to 44% of patients in STEP trials), diarrhoea, vomiting, constipation, and abdominal pain. These typically occur during dose escalation phases and often diminish as your body adjusts to each new dose level. Mounjaro shows similar gastrointestinal effects but may have a slightly different onset pattern due to its dual-hormone approach, though both require careful monitoring during the initial months of treatment.
Wegovy vs Mounjaro Pricing and Value for Side Effects Management
Understanding the side effects of Wegovy becomes more important when considering the financial commitment involved in long-term treatment. At EverydayMeds, Wegovy starts at £79.99 for the 0.25mg starter dose (with code FIRST40), progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our bundle options like the Intro Trio (£299.99) provide three months of step-up dosing, allowing you to monitor side effects gradually whilst ensuring supply continuity. Returning customers benefit from code DOSE25 applied at checkout for ongoing savings.
Mounjaro follows a different dosing schedule with six dose levels (2.5mg to 15mg), which may mean a different side effect timeline compared to Wegovy's five-dose escalation. Both medications are available through our GPhC-registered pharmacy (#9012878), allowing you to switch between treatments if side effects become problematic with your initial choice. Our clinical team reviews all assessments within three working days (or 24 hours with express service) to ensure appropriate prescribing based on your side effect tolerance and medical history.
Clinical Evidence for Side Effects of Wegovy Compared to Mounjaro
The side effects of Wegovy have been extensively documented in the STEP clinical trial programme, as reported by Wilding et al. in the New England Journal of Medicine (2021). In STEP 1, the most common treatment-emergent adverse events were gastrointestinal, with nausea being dose-dependent and typically transient during escalation phases. Discontinuation rates due to side effects were approximately 7% in the Wegovy group versus 3% with placebo, indicating that whilst side effects occur, most patients can continue treatment successfully.
Comparative studies between semaglutide and tirzepatide mechanisms suggest different receptor binding may influence side effect profiles, though head-to-head trials are limited. Both medications carry MHRA additional monitoring (Black Triangle ▼) status, requiring careful surveillance of side effects in real-world use. Your prescriber will assess your individual risk factors and previous medication tolerances when determining which treatment may be more appropriate for your circumstances.
How Wegovy Works and Common Side Effects of Wegovy
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone to reduce appetite and promote feelings of fullness after smaller meals. This mechanism works on brain appetite centres, particularly in the hypothalamus, to influence food intake and cravings. The medication slows gastric emptying, which explains why gastrointestinal side effects are most common, especially during the initial weeks of treatment. As a prescription-only medicine, Wegovy must be used alongside a reduced-calorie diet and increased physical activity to achieve optimal results. Understanding how the medication works helps explain why certain side effects occur and why they typically improve as your digestive system adapts to the treatment.
EverydayMeds Ordering Process for Side Effects of Wegovy Assessment
Our streamlined process begins with a comprehensive 3-minute clinical assessment that specifically evaluates your suitability for weight management medications and potential side effect risk factors. During this assessment, you'll be asked about previous medication experiences, current health conditions, and any factors that might influence your tolerance to GLP-1 receptor agonists like Wegovy. Our qualified prescribers review every application thoroughly, considering your individual circumstances to determine whether Wegovy, Mounjaro, or alternative treatments might be most appropriate. Once approved, your medication is dispatched via next-day delivery using our temperature-controlled cold-chain system to maintain medication integrity. This careful handling ensures you receive your prescription-only medicine in optimal condition, ready for safe self-administration following the provided instructions.
Storage Considerations Affecting Side Effects of Wegovy
Proper storage of Wegovy can influence both medication effectiveness and side effect management, making this a crucial consideration when comparing treatment options. Wegovy requires refrigeration at 2-8°C before first use but offers superior travel convenience with up to 6 weeks of room temperature storage below 30°C, compared to Mounjaro's 21-day limit. The FlexTouch pen design allows for easy self-injection once weekly, typically in the thigh, abdomen, or upper arm, with rotation between injection sites recommended to minimise local side effects. Each dose escalation from 0.25mg through to the 2.4mg maintenance dose is designed to gradually introduce your system to higher medication levels, helping to minimise the intensity of common gastrointestinal side effects. Following the prescribed escalation schedule is essential, as skipping doses or escalating too quickly can increase the likelihood and severity of side effects.
Comparing Side Effects of Wegovy During Dose Escalation vs Mounjaro
The side effects of Wegovy follow a predictable pattern during the five-stage dose escalation, with most patients experiencing peak gastrointestinal symptoms during the first few days after each dose increase. Wegovy's escalation schedule spans 16 weeks to reach maintenance dosing, allowing gradual adaptation that may reduce side effect severity compared to more rapid escalation protocols. Each four-week period at a stable dose allows your digestive system to adjust before the next increase, with many patients reporting that nausea and other side effects diminish significantly by the third week of each dose level.
Mounjaro's six-dose escalation follows a different timeline, potentially offering more granular dose adjustments but requiring longer overall escalation periods to reach maximum therapeutic doses. The choice between these escalation patterns may influence your side effect experience, with some patients preferring Wegovy's more established five-dose protocol whilst others benefit from Mounjaro's additional intermediate steps. Your prescriber can help determine which approach aligns better with your tolerance profile and lifestyle requirements.
Making Your Choice: Side Effects of Wegovy vs Mounjaro at EverydayMeds
As the only UK online pharmacy offering both Wegovy and Mounjaro through our GPhC-registered service (#9012878), we're uniquely positioned to help you make an informed choice about which treatment may suit your side effect tolerance and lifestyle needs. Both medications are prescription-only medicines requiring careful medical supervision, but having access to both options means you're not limited to a single treatment pathway if your initial choice proves unsuitable. Our clinical team maintains detailed records of patient experiences with both medications, allowing us to provide evidence-based guidance on which option might be preferable based on your individual circumstances. Start your assessment today at https://everydaymeds.co.uk/collections/weight-loss, using code FIRST40 for new customers or DOSE25 for returning patients, and take the first step towards effective, medically-supervised weight management. Remember that both Wegovy and Mounjaro require commitment to lifestyle changes including reduced-calorie diet and increased physical activity, making the side effect profile just one factor in your treatment decision.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
